Correlation Between Diffusion Pharmaceuticals and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Akari Therapeutics PLC, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Akari Therapeutics.
Diversification Opportunities for Diffusion Pharmaceuticals and Akari Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Diffusion and Akari is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and Akari Therapeutics
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Diffusion Pharmaceuticals is 1.8 times less risky than Akari Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 1,118 in Akari Therapeutics PLC on August 26, 2024 and sell it today you would lose (988.00) from holding Akari Therapeutics PLC or give up 88.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 32.06% |
| Values | Daily Returns |
Diffusion Pharmaceuticals vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akari Therapeutics PLC |
Diffusion Pharmaceuticals and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diffusion Pharmaceuticals and Akari Therapeutics
The main advantage of trading using opposite Diffusion Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |